Mortality associated with the use of non‐vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban
Yu‐Sheng Lin, Feng‐Che Kuan, Tze‐Fan Chao, Michael Shengtao WU et autres
OBJECTIVE: This study assesses the mortality outcomes of non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with venous thromboembolism (VTE) and atrial fibrillation (AF). METHODS: Medical records of cancer patients receiving NOACs for VTE or AF between January 1, 2011, and …
tw, us, gb, dk (code pays fourni par la source)